| 
 | 
PKI-402
Description of:PKI-402 
PKI-402 gave rise to in vitro growth inhibition of human tumor cell lines derived from breast, brain (glioma), pancreas,...
More>> 
 | 
 
 
             | 
          
| 
 | 
XL147
Description of:XL147 
XL147 reversibly binds to class 1 PI3Ks in an ATP-competitive manner, inhibiting the production of PIP3 and activation of ...
More>> 
 | 
 
 
             | 
          
| 
 | 
PIK90
Description of:PIK90 
PIK-90 is a PI3K inhibitor,IC50=11, 350, 18, and 58 for p110 α, β, γ and δ isoforms. 
Theor...
More>> 
 | 
 
 
             | 
          
| 
 | 
XL765
Description of:XL765 
XL765 is a mixed mTOR/PI3k inhibitor with IC50 of 157, 39, 113, 9 and 43 nM for mTOR, p110α, β, γ and &de...
More>> 
 | 
 
 
             | 
          
| 
 | 
CAL101
Description of:CAL101 
CAL-101 blocked constitutive phosphatidylinositol-3-kinase signaling, resulting in decreased phosphorylation of Akt and o...
More>> 
 | 
 
 
             | 
          
| 
 | 
A66
 Description of:A66 
A66 is a highly specific and selective p110α inhibitor with IC50 of 32,30 and 43 nM for p110α, p110α...
More>> 
 | 
 
 
             | 
          
| 
 | 
PIK-75
Description of:PIK-75 
Cell-based assays revealed that PIK-75 potently and dose dependently inhibits in vitro and in vivo production of TNF-alph...
More>> 
 | 
 
 
             | 
          
| 
 | 
GDC-0941
Description of:GDC-0941 
GDC-0941 was much less potent on mTOR and DNA-PK. Importantly, the activity of GDC-0941 against the panel of human tumo...
More>> 
 | 
 
 
             | 
          
| 
 | 
BEZ235(NVP-BEZ235)
Description of:BEZ235(NVP-BEZ235) 
NVP-BEZ235 inhibited the activation of the downstream effectors Akt, S6 ribosomal protein, and 4EBP1 in breas...
More>> 
 | 
 
 
             | 
          
| 
 | 
ZSTK474
Description of:ZSTK474 
ZSTK474 has strong antitumor activities against human cancer xenografts (A549, PC-3 and WiDr) when administered orally t...
More>> 
 | 
 
 
             |